{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:55:38Z","timestamp":1791024938852,"version":"4.1.0"},"reference-count":174,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of the People's Republic of China","doi-asserted-by":"publisher","award":["GZY-KJS-SD-2023-051"],"award-info":[{"award-number":["GZY-KJS-SD-2023-051"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2023QH245"],"award-info":[{"award-number":["ZR2023QH245"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejpb.2026.115238","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:48:44Z","timestamp":1789516124000},"page":"115238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting the choroidal neovascularization microenvironment: new perspectives in nanotherapeutic strategies"],"prefix":"10.1016","volume":"228","author":[{"given":"Xiaoyan","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0587-6810","authenticated-orcid":false,"given":"Yongchao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.ejpb.2026.115238_b0005","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration","volume":"355","author":"Brown","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115238_b0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4068\/cmj.2023.59.3.143","article-title":"Mechanistic insight into age-related macular degeneration (AMD): anatomy, epidemiology, genetics, pathogenesis, prevention, implications, and treatment strategies to pace AMD management","volume":"59","author":"Amini","year":"2023","journal-title":"Chonnam Med. J."},{"issue":"10386","key":"10.1016\/j.ejpb.2026.115238_b0015","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(22)02609-5","article-title":"Age-related macular degeneration","volume":"401","author":"Guymer","year":"2023","journal-title":"Lancet (london, England)"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0020","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","article-title":"Age-related macular degeneration","volume":"7","author":"Fleckenstein","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"14","key":"10.1016\/j.ejpb.2026.115238_b0025","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115238_b0030","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1517\/14656566.2012.658368","article-title":"Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration","volume":"13","author":"Ohr","year":"2012","journal-title":"Expert Opin. Pharmacother."},{"issue":"19","key":"10.1016\/j.ejpb.2026.115238_b0035","doi-asserted-by":"crossref","first-page":"10533","DOI":"10.1021\/acs.jmedchem.9b01033","article-title":"Ocular disease therapeutics: design and delivery of drugs for diseases of the eye","volume":"63","author":"Cheng","year":"2020","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.ejpb.2026.115238_b0040","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1038\/s41433-025-03997-7","article-title":"Intravitreal faricimab for diabetic macular oedema and neovascular age-related macular degeneration: general considerations and practical recommendations by an expert panel of italian retina specialists","volume":"39","author":"Borrelli","year":"2025","journal-title":"Eye (Lond.)"},{"key":"10.1016\/j.ejpb.2026.115238_b0045","doi-asserted-by":"crossref","unstructured":"M. Schargus, A. Frings, Issues with intravitreal administration of anti-VEGF drugs, Clinical Ophthalmology (Auckland, N.Z.) 14 (2020) 897-904, doi: 10.2147\/OPTH.S207978.","DOI":"10.2147\/OPTH.S207978"},{"key":"10.1016\/j.ejpb.2026.115238_b0050","doi-asserted-by":"crossref","unstructured":"M.M. Popovic, M. Balas, S.R. Sadda, D. Sarraf, R. Huang, S.J. Bakri, A. Berrocal, A. Chang, C.M. Gemmy Cheung, S. Garg, R.J. Hillier, F.G. Holz, M.W. Johnson, P.K. Kaiser, P.J. Kertes, T.Y.Y. Lai, J. Noble, S.S. Park, Y.M. Paulus, G. Querques, A. Rachitskaya, P. Ruamviboonsuk, S. Saidkasimova, M.T. Sandinha, D.H. Steel, H. Terasaki, C.Y. Weng, B.K.J. Williams, L. Wu, R.H. Muni, International classification system for ocular complications of anti-VEGF agents in clinical trials, Ophthalmology 131 (12) (2024) 1457-1467, doi: 10.1016\/j.ophtha.2024.06.011.","DOI":"10.1016\/j.ophtha.2024.06.011"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.51329\/mehdiophthal1539","article-title":"Systemic and ocular complications related to intravitreal administration of anti-VEGF agents","volume":"15","author":"Koksaldi","year":"2026","journal-title":"Medical Hypothesis, Discovery & Innovation Ophthalmology Journal"},{"key":"10.1016\/j.ejpb.2026.115238_b0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.preteyeres.2020.100906","article-title":"Incomplete response to anti-VEGF therapy in neovascular AMD : exploring disease mechanisms and therapeutic opportunities","volume":"82","author":"Mettu","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40942-022-00363-7","article-title":"Fluid dynamics between injections in incomplete anti-VEGF responders within neovascular age-related macular degeneration: a prospective observational study","volume":"8","author":"Gigon","year":"2022","journal-title":"Int. J. Retina Vitr."},{"key":"10.1016\/j.ejpb.2026.115238_b0070","first-page":"1857","article-title":"Resistance to anti-VEGF therapy in neovascular age-related macular degeneration : a comprehensive review","volume":"10","author":"Yang","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115238_b0075","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.survophthal.2024.12.004","article-title":"Inflammatory choroidal neovascularization : an evidence-based update","volume":"70","author":"Servillo","year":"2025","journal-title":"Surv. Ophthalmol."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115238_b0080","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"issue":"13","key":"10.1016\/j.ejpb.2026.115238_b0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/ijms26136174","article-title":"Age-related macular degeneration: cellular and molecular signaling mechanisms","volume":"26","author":"Jiang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12929-024-01036-3","article-title":"Contribution of extracellular vesicles for the pathogenesis of retinal diseases : shedding light on blood- retinal barrier dysfunction","volume":"31","author":"Martins","year":"2024","journal-title":"J. Biomed. Sci."},{"issue":"10","key":"10.1016\/j.ejpb.2026.115238_b0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.heliyon.2024.e30840","article-title":"Role of macrophage in ocular neovascularization","volume":"10","author":"Tu","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2025.09.002","article-title":"The role of lipid metabolism disorder in the progression and treatment of ocular vascular diseases","volume":"71","author":"Song","year":"2026","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ejpb.2026.115238_b0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.exer.2025.110303","article-title":"Features that distinguish age-related macular degeneration from aging","volume":"254","author":"Skowronska-Krawczyk","year":"2025","journal-title":"Exp. Eye Res."},{"issue":"10","key":"10.1016\/j.ejpb.2026.115238_b0110","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.4103\/NRR.NRR-D-25-01905","article-title":"Retinal glial cells in glaucoma and age-related retinal diseases: inflammatory responses, disease transitions, and translational perspectives","volume":"21","author":"Salkar","year":"2026","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ejpb.2026.115238_b0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1155\/2014\/768026","article-title":"Oxidative stress , hypoxia , and autophagy in the neovascular processes of age-related macular degenerati","volume":"2014","author":"Blasiak","year":"2014","journal-title":"Biomed Res. Int."},{"issue":"9","key":"10.1016\/j.ejpb.2026.115238_b0120","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/pharmaceutics13091376","article-title":"From oxidative stress to inflammation in the posterior ocular diseases : diagnosis and treatment","volume":"13","author":"Dammak","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115238_b0125","doi-asserted-by":"crossref","unstructured":"N. Kushwah, K. Bora, M. Maurya, M.C. Pavlovich, J. Chen, Oxidative stress and antioxidants in age-related macular degeneration, Antioxidants (Basel, Switzerland) 12 (7) (2023) 1379, doi: 10.3390\/antiox12071379.","DOI":"10.3390\/antiox12071379"},{"key":"10.1016\/j.ejpb.2026.115238_b0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.exer.2026.111064","article-title":"Metabolic reprogramming and mitochondrial dynamics: novel therapeutic perspectives for age-related macular degeneration","volume":"269","author":"Hu","year":"2026","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejpb.2026.115238_b0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biomaterials.2026.124192","article-title":"Molybdenum-based antioxidative nanomedicine fighting against retinal pigment epithelium degeneration","volume":"333","author":"Ju","year":"2026","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115238_b0140","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.survophthal.2024.12.004","article-title":"Inflammatory choroidal neovascularization: an evidence-based update","volume":"70","author":"Servillo","year":"2025","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ejpb.2026.115238_b0145","article-title":"Narrative review on the role of oxidative stress in the pathomechanism of ocular diseases: update 2025","volume":"15","author":"Grzybowski","year":"2026","journal-title":"Biocell"},{"key":"10.1016\/j.ejpb.2026.115238_b0150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.preteyeres.2021.100954","article-title":"VEGFR1 signaling in retinal angiogenesis and microinflammation","volume":"84","author":"Uemura","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115238_b0155","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/ijms19123846","article-title":"The different facades of retinal and choroidal endothelial cells in response to hypoxia","volume":"19","author":"Alizadeh","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ejpb.2026.115238_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e30840","article-title":"Role of macrophage in ocular neovascularization","volume":"10","author":"Tu","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ejpb.2026.115238_b0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.preteyeres.2020.100858","article-title":"Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration","volume":"79","author":"Kaarniranta","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejpb.2026.115238_b0170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.addr.2023.114770","article-title":"Polymer - and lipid-based nanocarriers for ocular drug delivery : current status and future perspectives","volume":"196","author":"Han","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.ejpb.2026.115238_b0175","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.tibtech.2024.05.002","article-title":"Ocular RNA nanomedicine : engineered delivery nanoplatforms in treating eye diseases","volume":"42","author":"Zhang","year":"2024","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ejpb.2026.115238_b0180","doi-asserted-by":"crossref","unstructured":"X. Liu, Y. Bi, C. Wei, Y. Zhang, X. Liu, X. Guo, L. Zhao, J. Zhang, C. Wang, H. Gao, Engineered neutrophil nanovesicles for inhibiting corneal neovascularization by synergistic anti-inflammatory, anti-VEGF, and chemoexcited photodynamic therapy, Advanced Materials (Deerfield Beach, Fla.) 37 (14) (2025) e2411030, doi: 10.1002\/adma.202411030.","DOI":"10.1002\/adma.202411030"},{"issue":"9","key":"10.1016\/j.ejpb.2026.115238_b0185","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3390\/pharmaceutics13091376","article-title":"From oxidative stress to inflammation in the posterior ocular diseases: diagnosis and treatment","volume":"13","author":"Dammak","year":"2021","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115238_b0190","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202407340","article-title":"Progress in nanotechnology for treating ocular surface chemical injuries: reflecting on advances in ophthalmology","volume":"12","author":"Qi","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejpb.2026.115238_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114770","article-title":"Polymer- and lipid-based nanocarriers for ocular drug delivery: current status and future perspectives","volume":"196","author":"Han","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.ejpb.2026.115238_b0200","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.tibtech.2024.05.002","article-title":"Ocular RNA nanomedicine: engineered delivery nanoplatforms in treating eye diseases","volume":"42","author":"Zhang","year":"2024","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.ejpb.2026.115238_b0205","first-page":"17","article-title":"Emerging innovations in nano-enabled therapy against age-related macular degeneration : a paradigm shift","volume":"600","author":"Dubey","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115238_b0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/ijms24021064","article-title":"Choroidal neovascular membranes in retinal and choroidal tumors : origins , mechanisms , and effec","volume":"24","author":"Di Staso","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115238_b0215","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","article-title":"Consensus nomenclature for reporting neovascular age-related macular degeneration data consensus on neovascular age-related macular degeneration nomenclature study group","volume":"127","author":"Spaide","year":"2020","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/eye.2016.216","article-title":"Structural and molecular changes in the aging choroid: implications for age-related macular degeneration","volume":"31","author":"Chirco","year":"2017","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115238_b0225","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3390\/ijms24021064","article-title":"Choroidal neovascular membranes in retinal and choroidal tumors: origins, mechanisms, and effects","volume":"24","author":"Di Staso","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115238_b0230","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.mam.2012.04.005","article-title":"Understanding age-related macular degeneration (AMD): relationships between the photoreceptor \/ retinal pigment epithelium \/ bruch's membrane \/ choriocapillaris complex","volume":"33","author":"Bhutto","year":"2012","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.ejpb.2026.115238_b0235","first-page":"23","article-title":"Pathophysiology of non-neovascular age-related macular degeneration: the oil spill in bruch 's membrane and beyond","volume":"228","author":"Curcio","year":"2012","journal-title":"Ophthalmologica"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115238_b0240","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/iovs.67.3.34","article-title":"The science of rod-mediated dark adaptation, an outcome measure for age-related macular degeneration: the 2025 proctor medal lecture","volume":"67","author":"Curcio","year":"2026","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115238_b0245","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.preteyeres.2009.08.001","article-title":"Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein b-containing lipoproteins","volume":"28","author":"Curcio","year":"2009","journal-title":"Prog. Retin. Eye Res."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115238_b0250","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231011","article-title":"Microglia at sites of atrophy restrict the progression of retinal degeneration via galectin-3 and trem2","volume":"221","author":"Yu","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejpb.2026.115238_b0255","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.exer.2026.111095","article-title":"From systemic disease to the eye: why senescence deserves attention in ocular infections","volume":"270","author":"Maiti","year":"2026","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejpb.2026.115238_b0260","first-page":"15","article-title":"Supramolecular nrf2-activating peptide nanotherapeutics enable deep retinal penetration and RPE targeting for dry age-related macular degeneration","volume":"40","author":"Zheng","year":"2026","journal-title":"Mater. Today Bio"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0265","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12974-020-02010-0","article-title":"Ocular macrophage origin and heterogeneity during steady state and experimental choroidal neovascularization","volume":"17","author":"Droho","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejpb.2026.115238_b0270","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1155\/2016\/3164734","article-title":"The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior and posterior eye segments in adults","volume":"2016","author":"Nita","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"21","key":"10.1016\/j.ejpb.2026.115238_b0275","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.3390\/cells11213453","article-title":"A linkage between angiogenesis and inflammation in neovascular age-related macular degeneration","volume":"11","author":"Heloter\u00e4","year":"2022","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115238_b0280","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/ICL.0b013e31821fbd3e","article-title":"A review: role of ultraviolet radiation in age-related macular degeneration","volume":"37","author":"Chalam","year":"2011","journal-title":"Eye Contact Lens"},{"issue":"8","key":"10.1016\/j.ejpb.2026.115238_b0285","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1167\/tvst.14.8.42","article-title":"Identification of biomarkers for oxidative stress in age-related macular degeneration: combining transcriptomics and mendelian randomization analysis","volume":"14","author":"Chen","year":"2025","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0290","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.gendis.2021.02.009","article-title":"Age-related macular degeneration: epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy","volume":"9","author":"Deng","year":"2021","journal-title":"Genes Dis."},{"key":"10.1016\/j.ejpb.2026.115238_b0295","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7901270","article-title":"Central role of oxidative stress in age-related macular degeneration: evidence from a review of the molecular mechanisms and animal models","volume":"2020","author":"Abokyi","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.ejpb.2026.115238_b0300","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jare.2023.06.004","article-title":"Inhibition of oxidative stress-induced epithelial-mesenchymal transition in retinal pigment epithelial cells of age-related macular degeneration model by suppressing ERK activation","volume":"60","author":"Yang","year":"2024","journal-title":"J. Adv. Res."},{"issue":"7\u20138","key":"10.1016\/j.ejpb.2026.115238_b0305","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/02713680600801024","article-title":"A novel zinc compound (zinc monocysteine) enhances the antioxidant capacity of human retinal pigment epithelial cells","volume":"31","author":"Tate","year":"2006","journal-title":"Curr. Eye Res."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115238_b0310","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/15548627.2022.2069437","article-title":"Autophagy in age-related macular degeneration","volume":"19","author":"Kaarniranta","year":"2023","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115238_b0315","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.survophthal.2020.09.002","article-title":"Oxidative stress as a therapeutic target for the prevention and treatment of early age-related macular degeneration","volume":"66","author":"Jabbehdari","year":"2021","journal-title":"Surv. Ophthalmol."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0320","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1167\/iovs.10-5595","article-title":"The role of RPE cell-associated VEGF??? In choroidal endothelial cell transmigration across the RPE","volume":"52","author":"Wang","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115238_b0325","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.2353\/ajpath.2010.090878","article-title":"The role of vascular endothelial growth factor-induced activation of NADPH oxidase in choroidal endothelial cells and choroidal neovascularization","volume":"177","author":"Monaghan-Benson","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejpb.2026.115238_b0330","first-page":"231","article-title":"Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity","volume":"20","author":"Wang","year":"2014","journal-title":"Mol. Vis."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115238_b0335","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1089\/ars.2007.1556","article-title":"VEGF signaling through NADPH oxidase-derived ROS","volume":"9","author":"Ushio-Fukai","year":"2007","journal-title":"Antioxid. Redox Signal."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115238_b0340","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.3390\/ijms22031296","article-title":"Age-related macular degeneration: role of oxidative stress and blood vessels","volume":"22","author":"Ruan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2026.115238_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.107939","article-title":"Choriocapillaris dropout in early age-related macular degeneration","volume":"192","author":"Lutty","year":"2020","journal-title":"Exp. Eye Res."},{"issue":"11","key":"10.1016\/j.ejpb.2026.115238_b0350","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1001\/jamaophthalmol.2016.3519","article-title":"Histopathological insights into choroidal vascular loss in clinically documented cases of age-related macular degeneration","volume":"134","author":"Seddon","year":"2016","journal-title":"JAMA Ophthalmol."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0355","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.exer.2005.05.007","article-title":"Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration","volume":"82","author":"Bhutto","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejpb.2026.115238_b0360","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/690243","article-title":"NLRP3 inflammasome : activation and regulation in age-related macular degeneration","volume":"2015","author":"Gao","year":"2015","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115238_b0365","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00109-008-0418-z","article-title":"Age-related macular degeneration: activation of innate immunity system via pattern recognition receptors","volume":"87","author":"Kaarniranta","year":"2009","journal-title":"J. Mol. Med. (Berl)"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0370","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000492886","article-title":"Oxidative stress is the principal contributor to inflammasome activation in retinal pigment epithelium cells with defunct proteasomes and autophagy","volume":"49","author":"Piippo","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"18","key":"10.1016\/j.ejpb.2026.115238_b0375","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1523\/JNEUROSCI.0190-15.2015","article-title":"Investigating mitochondria as a target for treating age-related macular degeneration","volume":"35","author":"Terluk","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejpb.2026.115238_b0380","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.exer.2019.04.009","article-title":"High-throughput screening identifies compounds that protect RPE cells from physiological stressors present in AMD","volume":"185","author":"Cai","year":"2019","journal-title":"Exp. Eye Res."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115238_b0385","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0014-4835(03)00023-X","article-title":"Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration","volume":"76","author":"Liang","year":"2003","journal-title":"Exp. Eye Res."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115238_b0390","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/antiox15060713","article-title":"Epigenetic-mitochondrial-metabolic crosstalk in retinal pigment epithelium (RPE) dysfunction in age-related macular degeneration (AMD)","volume":"15","author":"Yang","year":"2026","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.ejpb.2026.115238_b0395","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.preteyeres.2008.09.001","article-title":"Mitochondrial DNA damage and its potential role in retinal degeneration","volume":"27","author":"Jarrett","year":"2008","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejpb.2026.115238_b0400","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.freeradbiomed.2016.02.027","article-title":"Malondialdehyde induces autophagy dysfunction and VEGF secretion in the retinal pigment epithelium in age-related macular degeneration","volume":"94","author":"Ye","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejpb.2026.115238_b0405","doi-asserted-by":"crossref","unstructured":"S.K. Mitter, C. Song, X. Qi, H. Mao, H. Rao, D. Akin, A. Lewin, M. Grant, W.J. Dunn, J. Ding, C. Bowes Rickman, M. Boulton, Dysregulated autophagy in the RPE is associated with increased susceptibility to oxidative stress and AMD, Autophagy 10 (11) (2014) 1989-2005, doi: 10.4161\/auto.36184.","DOI":"10.4161\/auto.36184"},{"key":"10.1016\/j.ejpb.2026.115238_b0410","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.preteyeres.2017.03.002","article-title":"The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD","volume":"60","author":"Datta","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115238_b0415","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.ajpath.2011.01.013","article-title":"Interleukin-1\u03b2 inhibition prevents choroidal neovascularization and does not exacerbate photoreceptor degeneration","volume":"178","author":"Lavalette","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115238_b0420","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/09273940802710705","article-title":"Intravitreal anakinra inhibits choroidal neovascular membrane growth in a rat model","volume":"17","author":"Olson","year":"2009","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.ejpb.2026.115238_b0425","first-page":"116","article-title":"TNF-\u03b1 mediates choroidal neovascularization by upregulating VEGF expression in RPE through ROS-dependent \u03b2-catenin activation","volume":"22","author":"Wang","year":"2016","journal-title":"Mol. Vis."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115238_b0430","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.2353\/ajpath.2007.061018","article-title":"Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization","volume":"170","author":"Izumi-Nagai","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejpb.2026.115238_b0435","first-page":"184","article-title":"Pro-angiogenic effect of IFNgamma is dependent on the PI3k\/mTOR\/translational pathway in human retinal pigmented epithelial cells","volume":"16","author":"Liu","year":"2010","journal-title":"Mol. Vis."},{"issue":"10","key":"10.1016\/j.ejpb.2026.115238_b0440","doi-asserted-by":"crossref","first-page":"6968","DOI":"10.1167\/iovs.14-15029","article-title":"Interleukin-17 induces angiogenesis in human choroidal endothelial cells in vitro","volume":"55","author":"Chen","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0445","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/09114300.2018.1451609","article-title":"Interleukin-6 plays a crucial role in the development of subretinal fibrosis in a mouse model","volume":"41","author":"Sato","year":"2018","journal-title":"Immunol. Med."},{"key":"10.1016\/j.ejpb.2026.115238_b0450","doi-asserted-by":"crossref","first-page":"7847","DOI":"10.1038\/ncomms8847","article-title":"IL10-driven STAT3 signalling in senescent macrophages promotes pathological eye angiogenesis","volume":"6","author":"Nakamura","year":"2015","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.ejpb.2026.115238_b0455","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.3390\/ijms26136174","article-title":"Age-related macular degeneration: cellular and molecular signaling mechanisms","volume":"26","author":"Jiang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.ejpb.2026.115238_b0460","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.7150\/ijbs.49890","article-title":"The role of inflammation in age-related macular degeneration","volume":"16","author":"Tan","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"14","key":"10.1016\/j.ejpb.2026.115238_b0465","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1167\/iovs.19-27493","article-title":"Chitinase-3-like-1 promotes m2 macrophage differentiation and induces choroidal neovascularization in neovascular age-related macular degeneration","volume":"60","author":"Xu","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.ejpb.2026.115238_b0470","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.celrep.2015.01.050","article-title":"ROCK-isoform-specific polarization of macrophages associated with age-related macular degeneration","volume":"10","author":"Zandi","year":"2015","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115238_b0475","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2174\/1566524016666160324130031","article-title":"STAT3 activation in circulating monocytes contributes to neovascular age-related macular degeneration","volume":"16","author":"Chen","year":"2016","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ejpb.2026.115238_b0480","unstructured":"P.A. Campochiar, Molecular pathogenesis of retinal and choroidal vascular diseases*."},{"key":"10.1016\/j.ejpb.2026.115238_b0485","doi-asserted-by":"crossref","unstructured":", Prog. Retin. Eye Res. (49) (2015) 67-81, doi: 10.1016\/j.preteyeres.2015.06.002.","DOI":"10.1016\/j.preteyeres.2015.06.002"},{"key":"10.1016\/j.ejpb.2026.115238_b0490","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13024-018-0243-y","article-title":"Targeting hif1a rescues cone degeneration and prevents subretinal neovascularization in a model of chronic hypoxia","volume":"13","author":"Barben","year":"2018","journal-title":"Mol. Neurodegener."},{"issue":"13","key":"10.1016\/j.ejpb.2026.115238_b0495","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1096\/fj.202400540RRR","article-title":"Inhibition of hypoxia-inducible factors suppresses subretinal fibrosis","volume":"38","author":"Shoda","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.ejpb.2026.115238_b0500","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/768026","article-title":"Oxidative stress, hypoxia, and autophagy in the neovascular processes of age-related macular degeneration","volume":"2014","author":"Blasiak","year":"2014","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.ejpb.2026.115238_b0505","doi-asserted-by":"crossref","unstructured":"A. Klettner, J. Roider, Constitutive and oxidative-stress-induced expression of VEGF in the RPE are differently regulated by different mitogen-activated protein kinases, Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie 247 (11) (2009) 1487-1492, doi: 10.1007\/s00417-009-1139-x.","DOI":"10.1007\/s00417-009-1139-x"},{"key":"10.1016\/j.ejpb.2026.115238_b0510","first-page":"1649","article-title":"Stimulation of apical and basolateral VEGF-a and VEGF-c secretion by oxidative stress in polarized retinal pigment epithelial cells","volume":"12","author":"Kannan","year":"2006","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ejpb.2026.115238_b0515","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.preteyeres.2015.06.002","article-title":"Molecular pathogenesis of retinal and choroidal vascular diseases","volume":"49","author":"Campochiaro","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejpb.2026.115238_b0520","first-page":"4c","article-title":"Multifunctional nanotherapeutics with long-acting release against macular degeneration by minimally invasive administration","author":"Chang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejpb.2026.115238_b0525","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2025.114394","article-title":"Multifunctional macrophage membrane biomimetic nanoparticles for targeted therapy of neovascular age-related macular degeneration","volume":"388","author":"Yin","year":"2025","journal-title":"J. Control. Release"},{"issue":"31","key":"10.1016\/j.ejpb.2026.115238_b0530","article-title":"Red light\u2010triggered anti\u2010angiogenic and photodynamic combination therapy of age\u2010related macular degeneration","volume":"10","author":"Xu","year":"2023","journal-title":"Adv. Sci."},{"issue":"10","key":"10.1016\/j.ejpb.2026.115238_b0535","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202419263","article-title":"The optimized lipid\u2010modified prodrug for CNV treatment","volume":"37","author":"Lv","year":"2025","journal-title":"Adv. Mater."},{"issue":"38","key":"10.1016\/j.ejpb.2026.115238_b0540","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adu5571","article-title":"Nanozyme eye drops for retinal barrier penetration and vasculopathy repair","volume":"11","author":"Xue","year":"2025","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115238_b0545","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1021\/acsnano.7b00429","article-title":"Glycol chitosan engineered autoregenerative antioxidant significantly attenuates pathological damages in models of age-related macular degeneration","volume":"11","author":"Mitra","year":"2017","journal-title":"ACS Nano"},{"issue":"9","key":"10.1016\/j.ejpb.2026.115238_b0550","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202408436","article-title":"Supramolecular engineering of nanoceria for management and amelioration of age\u2010related macular degeneration via the two\u2010level blocking of oxidative stress and inflammation","volume":"12","author":"Xu","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejpb.2026.115238_b0555","article-title":"ROS-responsive drug delivery system with enhanced anti-angiogenic and anti-inflammatory properties for neovascular age-related macular degeneration therapy","volume":"32","author":"Zuo","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0560","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1186\/s12951-024-02943-1","article-title":"Targeting glutamine synthetase with as1411-modified exosome-liposome hybrid nanoparticles for inhibition of choroidal neovascularization","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.ejpb.2026.115238_b0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113908","article-title":"Microneedle-mediated biomimetic nanoparticles for targeted antioxidant and anti-inflammatory therapy in age-related macular degeneration","volume":"384","author":"Liu","year":"2025","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0570","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.apsb.2021.05.021","article-title":"Accurate construction of cell membrane biomimetic graphene nanodecoys via purposeful surface engineering to improve screening efficiency of active components of traditional chinese medicine","volume":"12","author":"Hu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejpb.2026.115238_b0575","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jconrel.2021.05.035","article-title":"Systemic dendrimer nanotherapies for targeted suppression of choroidal inflammation and neovascularization in age-related macular degeneration","volume":"335","author":"Kambhampati","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.115238_b0580","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejpb.2015.02.013","article-title":"Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells","volume":"95","author":"Kambhampati","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115238_b0585","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.biomaterials.2011.10.010","article-title":"Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration","volume":"33","author":"Iezzi","year":"2012","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0590","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1021\/bm101046d","article-title":"Comparative biodistribution of PAMAM dendrimers and HPMA copolymers in ovarian-tumor-bearing mice","volume":"12","author":"Sadekar","year":"2011","journal-title":"Biomacromolecules"},{"issue":"23","key":"10.1016\/j.ejpb.2026.115238_b0595","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202314095","article-title":"Emerging co\u2010assembled and sustained released natural medicinal nanoparticles for multitarget therapy of choroidal neovascularization","volume":"36","author":"Shen","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejpb.2026.115238_b0600","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2147\/IJN.S126865","article-title":"Topical ocular delivery to laser-induced choroidal neovascularization by dual internalizing RGD and TAT peptide-modified nanoparticles","volume":"12","author":"Chu","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"16","key":"10.1016\/j.ejpb.2026.115238_b0605","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/cells11162573","article-title":"Intraocular RGD-engineered exosomes and active targeting of choroidal neovascularization (CNV)","volume":"11","author":"Pollalis","year":"2022","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115238_b0610","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.apsb.2021.10.022","article-title":"Intravenous route to choroidal neovascularization by macrophage-disguised nanocarriers for mTOR modulation","volume":"12","author":"Xia","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115238_b0615","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abq3104","article-title":"Eyedrop-based macromolecular ophthalmic drug delivery for ocular fundus disease treatment","volume":"9","author":"Shen","year":"2023","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0620","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1021\/acsnano.2c05824","article-title":"Highly retina-permeating and long-acting resveratrol\/metformin nanotherapeutics for enhanced treatment of macular degeneration","volume":"17","author":"Nguyen","year":"2023","journal-title":"ACS Nano"},{"issue":"28","key":"10.1016\/j.ejpb.2026.115238_b0625","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj0006","article-title":"Dynamically covalent lipid nanoparticles mediate CRISPR-cas9 genome editing against choroidal neovascularization in mice","volume":"11","author":"Cao","year":"2025","journal-title":"Sci. Adv."},{"issue":"33","key":"10.1016\/j.ejpb.2026.115238_b0630","doi-asserted-by":"crossref","first-page":"17298","DOI":"10.1039\/D0NR03710A","article-title":"Controlled release of anti-VEGF by redox-responsive polydopamine nanoparticles","volume":"12","author":"Jiang","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejpb.2026.115238_b0635","doi-asserted-by":"crossref","unstructured":"K. Huang, X. Liu, Z. Lv, Di Zhang, Y. Zhou, Z. Lin, J. Guo, MMP9-responsive graphene oxide quantum dot-based nano-in-micro drug delivery system for combinatorial therapy of choroidal neovascularization, Small 19 (39) (2023) 19, doi: 10.1002\/smll.202207335.","DOI":"10.1002\/smll.202207335"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115238_b0640","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/archophthalmol.2011.12","article-title":"Suppression of choroidal neovascularization by intravitreal injection of liposomal SU5416","volume":"129","author":"Honda","year":"2011","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0645","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1080\/10717544.2018.1474967","article-title":"Multivesicular liposomes for sustained release of bevacizumab in treating laser-induced choroidal neovascularization","volume":"25","author":"Mu","year":"2018","journal-title":"Drug Deliv."},{"issue":"11","key":"10.1016\/j.ejpb.2026.115238_b0650","doi-asserted-by":"crossref","first-page":"19412","DOI":"10.1021\/acsnano.2c09087","article-title":"Melanin - like nanoparticles as an alternative to natural melanin in retinal pigment epithelium cells and their therapeutic effects against age-related macular degeneration","volume":"16","author":"Kwon","year":"2022","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115238_b0655","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202204994","article-title":"Injectable anti\u2010inflammatory supramolecular nanofiber hydrogel to promote anti\u2010VEGF therapy in age\u2010related macular degeneration treatment","volume":"35","author":"Gao","year":"2023","journal-title":"Adv. Mater."},{"issue":"10","key":"10.1016\/j.ejpb.2026.115238_b0660","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202419263","article-title":"The optimized lipid-modified prodrug for CNV treatment","volume":"37","author":"Lv","year":"2025","journal-title":"Advanced Materials (deerfield Beach, Fla.)"},{"issue":"23","key":"10.1016\/j.ejpb.2026.115238_b0665","article-title":"Emerging co-assembled and sustained released natural medicinal nanoparticles for multitarget therapy of choroidal neovascularization, Advanced Materials (Deerfield Beach","volume":"36","author":"Shen","year":"2024","journal-title":"Fla.)"},{"key":"10.1016\/j.ejpb.2026.115238_b0670","doi-asserted-by":"crossref","unstructured":"M. Xu, Y. Zhou, Y. Xu, A. Shao, H. Han, J. Ye, Supramolecular engineering of nanoceria for management and amelioration of age-related macular degeneration via the two-level blocking of oxidative stress and inflammation, Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 12 (9) (2025) e2408436, doi: 10.1002\/advs.202408436.","DOI":"10.1002\/advs.202408436"},{"issue":"31","key":"10.1016\/j.ejpb.2026.115238_b0675","article-title":"Red light-triggered anti-angiogenic and photodynamic combination therapy of age-related macular degeneration","volume":"10","author":"Xu","year":"2023","journal-title":"Adv. Sci. (weinheim, Baden-Wurttemberg, Germany)"},{"issue":"22","key":"10.1016\/j.ejpb.2026.115238_b0680","doi-asserted-by":"crossref","first-page":"19315","DOI":"10.1021\/jacs.5c05187","article-title":"Sterically controlled cyclobutane-dioxetane ultrabright afterglow nanosystem for cyclic therapy of choroidal neovascularization in mice","volume":"147","author":"Zhang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"21","key":"10.1016\/j.ejpb.2026.115238_b0685","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"7","author":"Helmut Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejpb.2026.115238_b0690","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.redox.2014.01.019","article-title":"Optogenetic control of ROS production","volume":"2","author":"Wojtovich","year":"2014","journal-title":"Redox Biol."},{"issue":"10","key":"10.1016\/j.ejpb.2026.115238_b0695","article-title":"A novel \u201cinside-out\u201d intraocular nanomedicine delivery mode for nanomaterials' biological effect enhanced choroidal neovascularization occlusion and microenvironment regulation","volume":"35","author":"Jin","year":"2023","journal-title":"Adv. Mater. (Deerfield Beach Fla.)"},{"key":"10.1016\/j.ejpb.2026.115238_b0700","doi-asserted-by":"crossref","unstructured":"J. Xu, Y. Tu, Y. Wang, X. Xu, X. Sun, L. Xie, Q. Zhao, Y. Guo, Y. Gu, J. Du, S. Du, M. Zhu, E. Song, Prodrug of epigallocatechin-3-gallate alleviates choroidal neovascularization via down-regulating HIF-1\u03b1\/VEGF\/VEGFR2 pathway and m1 type macrophage\/microglia polarization, Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 121 (2020) 109606, doi: 10.1016\/j.biopha.2019.109606.","DOI":"10.1016\/j.biopha.2019.109606"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115238_b0705","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejpb.2026.115238_b0710","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2016\/6058147","article-title":"Tumor-associated macrophages and neutrophils in tumor microenvironment","volume":"2016","author":"Kim","year":"2016","journal-title":"Mediat. Inflamm."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115238_b0715","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","article-title":"The chemokine system in diverse forms of macrophage activation and polarization","volume":"25","author":"Mantovani","year":"2004","journal-title":"Trends Immunol."},{"issue":"11","key":"10.1016\/j.ejpb.2026.115238_b0720","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nri1224","article-title":"Ocular immune privilege: therapeutic opportunities from an experiment of nature","volume":"3","author":"Streilein","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.ejpb.2026.115238_b0725","doi-asserted-by":"crossref","first-page":"e2367","DOI":"10.1038\/cddis.2016.133","article-title":"Clearance of autophagy-associated dying retinal pigment epithelial cells - a possible source for inflammation in age-related macular degeneration","volume":"7","author":"Szatm\u00e1ri-T\u00f3th","year":"2016","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115238_b0730","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1089\/ars.2008.2270","article-title":"Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment","volume":"11","author":"Azad","year":"2009","journal-title":"Antioxid. Redox Signal."},{"issue":"9","key":"10.1016\/j.ejpb.2026.115238_b0735","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1167\/iovs.12-9827","article-title":"Induction of autophagy and cell death by tamoxifen in cultured retinal pigment epithelial and photoreceptor cells","volume":"53","author":"Cho","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"52","key":"10.1016\/j.ejpb.2026.115238_b0740","doi-asserted-by":"crossref","first-page":"57710","DOI":"10.1021\/acsami.0c17296","article-title":"Ophthalmic drops with nanoparticles derived from a natural product for treating age-related macular degeneration","volume":"12","author":"Xin","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"9","key":"10.1016\/j.ejpb.2026.115238_b0745","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/ijms23094899","article-title":"Antigen presentation and autophagy in teleost adaptive immunity","volume":"23","author":"Johnstone","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7182","key":"10.1016\/j.ejpb.2026.115238_b0750","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self-digestion","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0755","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41392-023-01642-x","article-title":"Smart nanoparticles for cancer therapy","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115238_b0760","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.clae.2025.102367","article-title":"Nanotechnology-based non-invasive strategies in ocular therapeutics : approaches , limitations to clinical translation , and safety concer","volume":"48","author":"Chaudhari","year":"2025","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.ejpb.2026.115238_b0765","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.exer.2025.110806","article-title":"Recent advances of novel nanoformulations combatting blue light hazards in the retina","volume":"264","author":"Ghosh","year":"2026","journal-title":"Exp. Eye Res."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115238_b0770","first-page":"425","article-title":"Innovative approaches to antiviral eye drop development: acyclovir and ganciclovir in focus","volume":"82","author":"Markowicz-Piasecka","year":"2025","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115238_b0775","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijpharm.2024.124899","article-title":"Nanocarrier- based , ocular drug delivery : challenges, prospects, and the therapeutic landscape in the united arab emirate","volume":"667","author":"Yabhouni","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"34","key":"10.1016\/j.ejpb.2026.115238_b0780","doi-asserted-by":"crossref","first-page":"22793","DOI":"10.1021\/acsnano.4c08486","article-title":"Advances in extracellular-vesicles-based diagnostic and therapeutic approaches for ocular diseases","volume":"18","author":"Su","year":"2024","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115238_b0785","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/btm2.10246","article-title":"Nanoparticles in the clinic : an update post COVID-19 vaccines","volume":"6","author":"Anselmo","year":"2021","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.ejpb.2026.115238_b0790","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jconrel.2026.114888","article-title":"Advances in stabilizing lipid -based nanoparticles: the central role of lyophilization","volume":"394","author":"Bautista-Lopez","year":"2026","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.ejpb.2026.115238_b0795","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clinre.2026.102892","article-title":"From one-size-fits-all to on-demand: personalized crispr gene editing for rare genetic liver diseases","volume":"50","author":"Quan","year":"2026","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"22","key":"10.1016\/j.ejpb.2026.115238_b0800","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/advs.202102640","article-title":"Cancer patient tissueoid with self-homing nano-targeting of metabolic inhibitor","volume":"8","author":"Yoon","year":"2021","journal-title":"Adv. Sci."},{"issue":"7","key":"10.1016\/j.ejpb.2026.115238_b0805","first-page":"769","article-title":"Paclitaxel anti-cancer therapeutics : from discovery to clinical use","volume":"23","author":"Yu","year":"2025","journal-title":"Chin. J. Nat. Med."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115238_b0810","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae - the first FDA-approved nano-drug : lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0815","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/pharmaceutics13010123","article-title":"Quantitative cryo-TEM reveals new structural details of doxil-like PEGylated liposomal doxorubicin formulation","volume":"13","author":"Nordstrom","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115238_b0820","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jconrel.2020.04.018","article-title":"Design principles of drug combinations for chemotherapy","volume":"323","author":"Wu","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.115238_b0825","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jconrel.2016.04.028","article-title":"Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin","volume":"232","author":"Petersen","year":"2016","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0830","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13046-025-03579-1","article-title":"The radioenhancer NBTXR3 : bridging physics and biology to improve radiotherapy outcomes and prime anti-tumor immunit","volume":"44","author":"Bienassis","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.ejpb.2026.115238_b0835","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/s41565-024-01754-7","article-title":"A translational framework to deliver nanomedicines to the clinic","volume":"19","author":"Joyce","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ejpb.2026.115238_b0840","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2014.06.005","article-title":"Issues and concerns in nanotech product development and its commercialization","volume":"193","author":"Kaur","year":"2014","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115238_b0845","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/biom15111592","article-title":"Nanotechnology-based delivery systems and retinal pigment epithelium: advances, targeting approaches, and translational challenges","volume":"15","author":"Nardella","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejpb.2026.115238_b0850","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bcp.2025.116902","article-title":"Advancements in age-related macular degeneration treatment: from traditional anti-VEGF to emerging therapies in gene, stem cell, and nanotechnology","volume":"236","author":"Wang","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"28","key":"10.1016\/j.ejpb.2026.115238_b0855","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1126\/sciadv.adj0006","article-title":"Dynamically covalent lipid nanoparticles mediate CRISPR-cas9 genome editing against choroidal neovascularization in mice","volume":"11","author":"Cao","year":"2025","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0860","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41467-022-35640-4","article-title":"Safeguarding genome integrity during gene-editing therapy in a mouse model of age-related macular degeneration","volume":"13","author":"Yin","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115238_b0865","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12943-025-02270-5","article-title":"Nanobodies targeting the tumor microenvironment and their formulation as nanomedicines","volume":"24","author":"Maksymova","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejpb.2026.115238_b0870","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.addr.2022.114239","article-title":"Imaging and therapeutic targeting of the tumor immune microenvironment with biologics","volume":"184","author":"Arnouk","year":"2022","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:49:18Z","timestamp":1791024558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126002596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":174,"alternative-id":["S0939641126002596"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115238","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the choroidal neovascularization microenvironment: new perspectives in nanotherapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115238"}}